Technology ID
TAB-4616
Plasmodium falciparum Strains for Therapeutic, Diagnostic, and Commercial Research Use
E-Numbers
E-020-2017-0
Lead Inventor
Aidoo, Michael
Lead IC
CDC
ICs
CDC
Applications
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Development Stages
Pre-clinical (in vivo)
This technology includes plasmodium falciparum parasites (PH1, Benin, FCQ79, Santa Lucia and Borneo) which have all been isolated from infected persons from various geographic locations and have been modified/adapted for growth in the laboratory for multiple uses. Plasmodium falciparum strain W2 is a parasite clone from a parasite isolate called Indochina III/CDC which in turn originated from a patient in Laos infected with chloroquine-resistant parasites. Gametocytes from W2 can be grown experimentally and used in experimental infection of chimpanzees and aotus monkeys.
Commercial Applications
Isolates can be used for therapeutics, diagnostics and as commercial research tools.
Competitive Advantages
Multiple uses and opportunities for further development.
Licensing Contact: